EG23760A - Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them - Google Patents

Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
EG23760A
EG23760A EG5599A EG5599A EG23760A EG 23760 A EG23760 A EG 23760A EG 5599 A EG5599 A EG 5599A EG 5599 A EG5599 A EG 5599A EG 23760 A EG23760 A EG 23760A
Authority
EG
Egypt
Prior art keywords
pentasaccharides
novel
processes
preparation
pharmaceutical compositions
Prior art date
Application number
EG5599A
Other languages
English (en)
Inventor
Maurice Petitou
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of EG23760A publication Critical patent/EG23760A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EG5599A 1998-01-19 1999-01-16 Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them EG23760A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9800514A FR2773801B1 (fr) 1998-01-19 1998-01-19 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
EG23760A true EG23760A (en) 2007-08-08

Family

ID=9521913

Family Applications (1)

Application Number Title Priority Date Filing Date
EG5599A EG23760A (en) 1998-01-19 1999-01-16 Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them

Country Status (38)

Country Link
US (1) US6670338B1 (cs)
EP (1) EP1049706B1 (cs)
JP (1) JP4695756B2 (cs)
KR (1) KR100533565B1 (cs)
CN (1) CN1172948C (cs)
AR (1) AR012779A1 (cs)
AT (1) ATE241637T1 (cs)
AU (1) AU744137B2 (cs)
BR (1) BR9907100B1 (cs)
CA (1) CA2318326C (cs)
CO (1) CO4970823A1 (cs)
CZ (1) CZ299817B6 (cs)
DE (1) DE69908298T2 (cs)
DK (1) DK1049706T3 (cs)
DZ (1) DZ2706A1 (cs)
EE (1) EE04194B1 (cs)
EG (1) EG23760A (cs)
ES (1) ES2200494T3 (cs)
FR (1) FR2773801B1 (cs)
GT (1) GT199900006A (cs)
HR (1) HRP20000479A8 (cs)
HU (1) HU228335B1 (cs)
IL (2) IL137240A0 (cs)
MY (1) MY125636A (cs)
NO (1) NO316894B1 (cs)
NZ (1) NZ505614A (cs)
PL (1) PL191098B1 (cs)
PT (1) PT1049706E (cs)
RU (1) RU2193040C2 (cs)
SA (1) SA99191114B1 (cs)
SI (1) SI1049706T1 (cs)
SK (1) SK284176B6 (cs)
TR (1) TR200002077T2 (cs)
TW (1) TW550267B (cs)
UA (1) UA61124C2 (cs)
UY (1) UY25357A1 (cs)
WO (1) WO1999036428A1 (cs)
ZA (1) ZA99357B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
KR101156273B1 (ko) * 2004-03-04 2012-06-13 프로젠 파마슈티칼즈 리미티드 황산화 올리고사카라이드 유도체
CN100338084C (zh) * 2004-07-02 2007-09-19 北京大学 抑制异种器官移植免疫排斥反应的五糖抗原的合成方法
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US20070191306A1 (en) * 2005-08-17 2007-08-16 Bristol-Myers Squibb Company FACTOR Xa INHIBITOR FORMULATION AND METHOD
EP1908768A1 (en) * 2006-10-05 2008-04-09 Endotis Pharma Anticoagulant compounds
MY153697A (en) 2008-05-30 2015-03-13 Momenta Pharmaceuticals Inc Saccharide structures and methods of making and using such structures
CA2735983A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
US8288515B2 (en) * 2009-07-31 2012-10-16 Reliable Biopharmaceutical Corporation Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
CA2839139A1 (en) 2011-06-17 2012-12-20 Carbomimetics Synthetic pentasaccharides having short half-life and high activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
DE69100275T2 (de) * 1990-04-23 1993-12-02 Akzo Nv Eine Trisaccharideinheit enthaltende Kohlenhydratderivate.
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
HUP0102042A3 (en) 2003-07-28
HRP20000479B8 (hr) 2025-09-12
HUP0102042A1 (hu) 2001-10-28
CZ299817B6 (cs) 2008-12-03
FR2773801B1 (fr) 2000-05-12
DZ2706A1 (fr) 2003-09-01
CO4970823A1 (es) 2000-11-07
NO20003661D0 (no) 2000-07-17
EE04194B1 (et) 2003-12-15
HRP20000479B1 (hr) 2006-04-30
PL191098B1 (pl) 2006-03-31
WO1999036428A1 (fr) 1999-07-22
ATE241637T1 (de) 2003-06-15
BR9907100A (pt) 2000-10-24
HRP20000479A8 (hr) 2025-09-12
KR100533565B1 (ko) 2005-12-06
NO20003661L (no) 2000-09-19
HK1029999A1 (zh) 2001-04-20
AR012779A1 (es) 2000-11-08
UY25357A1 (es) 2000-12-29
CN1172948C (zh) 2004-10-27
ZA99357B (en) 2000-07-19
CZ20002636A3 (cs) 2000-11-15
EP1049706A1 (fr) 2000-11-08
SA99191114B1 (ar) 2006-10-11
SK10792000A3 (sk) 2001-01-18
RU2193040C2 (ru) 2002-11-20
TR200002077T2 (tr) 2000-12-21
MY125636A (en) 2006-08-30
TW550267B (en) 2003-09-01
BR9907100B1 (pt) 2013-09-03
HU228335B1 (en) 2013-03-28
AU744137B2 (en) 2002-02-14
PT1049706E (pt) 2003-09-30
GT199900006A (es) 2000-07-12
DK1049706T3 (da) 2003-09-29
EE200000421A1 (et) 2003-06-16
UA61124C2 (en) 2003-11-17
IL137240A0 (en) 2001-07-24
SI1049706T1 (en) 2003-12-31
HRP20000479A2 (en) 2001-02-28
CN1293679A (zh) 2001-05-02
AU1974699A (en) 1999-08-02
EE200000421A (et) 2001-12-17
NZ505614A (en) 2003-02-28
KR20010034205A (ko) 2001-04-25
CA2318326C (en) 2010-07-06
SK284176B6 (sk) 2004-10-05
ES2200494T3 (es) 2004-03-01
CA2318326A1 (en) 1999-07-22
EP1049706B1 (fr) 2003-05-28
FR2773801A1 (fr) 1999-07-23
US6670338B1 (en) 2003-12-30
PL341874A1 (en) 2001-05-07
DE69908298T2 (de) 2004-04-01
IL137240A (en) 2007-10-31
NO316894B1 (no) 2004-06-14
DE69908298D1 (de) 2003-07-03
JP2002509154A (ja) 2002-03-26
JP4695756B2 (ja) 2011-06-08

Similar Documents

Publication Publication Date Title
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
IL145013A0 (en) Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
HUP0100225A3 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
IL131415A (en) Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0201343A3 (en) Hypolipidemic benzothiazepine compounds, process for their preparation and pharmaceutical compositions containing them
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
PL349448A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0100488A3 (en) Thienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0203821A3 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
IL137494A0 (en) Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
PL345354A1 (en) 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
HUP0105481A3 (en) Pharmaceutical compositions containing clarithromycin and process for their preparation and their use
HUP0003577A3 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
EG23760A (en) Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them